Cardiomyopathies Flashcards
Types
Dilated
Hypertrophic
Restrictive/obliterative
CHF
Types:
Dilated causes
Most common (90%) Often idiopathic (up to 50%)
Other causes: chronic Alcoholic wet Beriberi, Coxsackie B virus myocarditis, chronic Cocaine, Chagas disease, Doxorubicin, hemochromatosis, Peripartum cardiomyopathy
Types:
Dilated findings
S3, dilated heart on ultrasound, balloon apperance on CXR
Microscope: eccentric hypertrophy (sarcomere in series) with systolic dysfunction
Types:
Dilated treatment
Na+ restriction, ACE inhibitors, Diuretics, Digoxin, Heart transplant
Types:
Hypertrophic
IV septum too close to mitral valve leaflet, leading to outflow tract obstruction
60-70% familial
Autosomal dominant (beta myosin heavy chain mutation)
Causes of sudden death in young athletes
Associated with Friedreich’s ataxia
Types:
hypetrophic finding
Disoriented, tangled, hypertrophied myocardial fiber
Findings: normal sized heart, S4 apical pulse, systolic murmur.
Diastolic dysnfunction ensues.
Asymmetric concentric hypertrophy (sarcomere in parallel)
Types:
hypertrophic consequence and treatment
Proximity of IV to mitral leaftlet obstruction outflow tract, results in systolic murmur and syncopal episodes.
Treatment: beta blocker, non dihdropyridine CCB (verapamil)
Types:
restrictive/obliterative cardiomyopathy
Sarciodisis, amyloidosis, postradiation fibrosis, endocardial fibroelastosis (thick fibroelastic tissue in endocardium of young children)
Types:
restrictive/obliterative cardiomyopathy associated with
Loffler’s syndrome:
- endomyocardial fibrosis with a prominent eosinophilic infiltrate and hemochromatosis (dilated cardiomyopathy can also occur)
Types:
CHF
Inherited or acquired abn of cardiac structure or function.
Dyspnea, fatigue, signs (edema and rales)
Right heart failure 2/2 to Left heart failure.
Isolated right heart failure due to cor pulmonale
Types:
CHF treatment
ACEi,
beta blockers (except in acute decompensated)
ARBs
Spironolactone
Thiazide or loop for symptomatic relief.
Hydralazine with nitrate therpay improves symptom and mortality in selected pts